Management of Locoregional Recurrent Breast Cancer

Overview

About this study

The aims of this study are to develop an institutional recurrent breast cancer registry, including prior and future patients, which will be prospectively maintained to characterize the current management of patients with locally recurrent breast cancer.  Specifically, investigate the extent of operation, subsequent operations, use of radiation and re-radiation and timing and nature of systemic therapies and variables associated with selection of these modalities, and to analyze breast-cancer specific outcomes including rates of local re-recurrence, regional and distant recurrence, recurrence-free and breast-cancer specific survival.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients ≥ 18 years of age.
  • Diagnosed with recurrent breast cancer at Mayo Clinic Rochester.
  • Willing to provide research consent.

Exclusion Criteria:

  • Patients who did not provide research consent.

Eligibility last updated 3/8/23. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mary Mrdutt

Contact us for the latest status

Contact information:

Mary Mrdutt

(507) 284-2770

Mrdutt.Mary@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20550953

Mayo Clinic Footer